Explore the science
Advancing precision medicine
through innovative biotechnology
Axiloopra Therapeutics
At axiloopra, we're building the future of targeted therapeutics. Our team combines cutting-
edge molecular biology with computational design to develop treatments that are effective,
safe, and accessible.
We believe every patient deserves precision medicine that works.
Innovative approach Experienced team Patient-focused
What sets us apart
Contact us
Whether you're a potential partner, investor, or talented scientist
looking to make an impact, we'd love to hear from you.
An integrated
approach
Axiloopra's proprietary discovery engine
combines three breakthrough technologies:
High-throughput screening
Computational modeling
Targeted delivery systems
It allows us to move from target
identification to preclinical validation in
record time.
AX-101 is a first-in-class
inhibitor targeting a novel
pathway in solid tumors.
Oncology Neuronal disease Infectious diseases
This early-stage program is
in the discovery phase
In the pipeline
This early-stage program is
in the discovery phase
Contact us
We're actively seeking strategic partnerships to accelerate
development and expand our pipeline.
